Literature DB >> 590310

Dose dependence of the 14C-aminopyrine breath test. Intrasubject comparison of tracer and pharmacological doses.

I Gikalov, J Bircher.   

Abstract

Although the aminopyrine breath test has received much attention, the question has not yet been settled whether pharmacological or tracer doses of the drug should be used. Nine volunteers were given 14C-aminopyrine 9 mg/kg or a tracer amount, in a randomized sequence and according to a crossover design. The specific activity of 14CO2 in breath was significantly different only during the first hour. Up to the 8th hour the disappearance of 14CO2 from breath was smaller after the pharmacological (28.5 +/- SD 5.4%/h) than after the tracer dose (36.2 +/- 10.6%/h; p less than 0.05). The over-all disappearance of 14C-atoms from the subjects was significantly slower after the higher dose. In view of the smaller radiation exposure and the decreased risk of agranulocytosis, the use of a tracer dose appears preferable.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 590310     DOI: 10.1007/bf00609866

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  THE METABOLIC FATE OF FORMALDEHYDE-14-C INTRAPERITONEALLY ADMINISTERED TO THE RAT.

Authors:  W B NEELY
Journal:  Biochem Pharmacol       Date:  1964-08       Impact factor: 5.858

2.  Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines.

Authors:  B N LA DU; L GAUDETTE; N TROUSOF; B B BRODIE
Journal:  J Biol Chem       Date:  1955-06       Impact factor: 5.157

3.  On the pharmacokinetics of phenacetin in man.

Authors:  J Raaflaub; U C Dubach
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

4.  The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1950-06       Impact factor: 4.030

5.  Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.

Authors:  G W Hepner; E S Vesell
Journal:  N Engl J Med       Date:  1974-12-26       Impact factor: 91.245

6.  Some characteristics of hepatic microsomal systems which metabolize aminopyrine in the rat and rabbit.

Authors:  T E Gram; J T Wilson; J R Fouts
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

7.  Kinetics of CO2-HCO3 minus in normal adult males.

Authors:  H S Winchell; H Stahelin; N Kusubov; B Slanger; M Fish; M Pollycove; J H Lawrence
Journal:  J Nucl Med       Date:  1970-12       Impact factor: 10.057

8.  Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat.

Authors:  B H Lauterburg; J Bircher
Journal:  J Pharmacol Exp Ther       Date:  1976-02       Impact factor: 4.030

9.  Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.

Authors:  G W Hepner; E S Vesell
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

10.  Aminopyrine demethylation measured by breath analysis in cirrhosis.

Authors:  J Bircher; A Küpfer; I Gikalov; R Preisig
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

View more
  13 in total

1.  The 14C-aminophenazone breath test in pesticide workers.

Authors:  B Dietze; K O Haustein; G Hüller; C Brückner
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

2.  The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis.

Authors:  R Carlisle; J T Galambos; W D Warren
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

3.  Individual theophylline dosing based on bioelectrical impedance analysis.

Authors:  J S Sidhu; E J Triggs; B G Charles; B A Smithurst
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

Review 4.  Effect of acute and chronic exercise on hepatic drug metabolism.

Authors:  M Døssing
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

5.  Liver function in physically trained subjects: galactose elimination capacity, plasma disappearance of indocyanine green, and aminopyrine metabolism in long-distance runners.

Authors:  J J Ducry; H Howald; T Zysset; J Bircher
Journal:  Dig Dis Sci       Date:  1979-03       Impact factor: 3.199

6.  A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs.

Authors:  D P Thornhill; C Steffen; K J Netter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

7.  Chemotherapy of larval echinococcosis with mebendazole: microsomal liver function and cholestasis as determinants of plasma drug level.

Authors:  F Witassek; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Development of N-demethylase activity measured with the 13C-aminopyrine breath test.

Authors:  E Jäger-Roman; D Rating; T Platzek; H Helge
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

9.  Use of a 13C-aminopyrine blood test: first clinical impressions.

Authors:  Deirdre Chiaramonte; Jörg M Steiner; John D Broussard; Keith Baer; Sheila Gumminger; Erik M Moeller; David A Williams; Renée Shumway
Journal:  Can J Vet Res       Date:  2003-07       Impact factor: 1.310

10.  Rate of drug metabolism in man measured by 14CO2-breath analysis.

Authors:  R Platzer; R L Galeazzi; G Karlaganis; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.